AG
TVTX icon

Algert Global’s Travere Therapeutics TVTX Stock Holding History

Algert Global’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45M Sell
166,372
-10,536
-6% -$467K 0.11% 286
2026
Q1 		$5.26M Buy
176,908
+26,970
+18% +$806K 0.08% 429
2025
Q4 		$5.73M Sell
149,938
-3,710
-2% -$121K 0.09% 382
2025
Q3 		$3.67M Buy
153,648
+26,460
+21% +$497K 0.06% 496
2025
Q2 		$1.88M Buy
127,188
+111,021
+687% +$1.84M 0.04% 650
2025
Q1 		$290K Hold
16,167
– – 0.01% 1020
2024
Q4 		$282K Buy
+16,167
New +$286K 0.01% 1003
2024
Q1 		– Sell
-83,840
Closed -$754K – 1277
2023
Q4 		$754K Buy
83,840
+4,470
+6% +$32.5K 0.03% 693
2023
Q3 		$710K Buy
79,370
+27,070
+52% +$382K 0.03% 643
2023
Q2 		$803K Buy
+52,300
New +$951K 0.04% 704
2023
Q1 		– Sell
-47,422
Closed -$997K – 1311
2022
Q4 		$997K Sell
47,422
-10,200
-18% -$216K 0.06% 571
2022
Q3 		$1.42M Buy
57,622
+4,720
+9% +$122K 0.09% 402
2022
Q2 		$1.28M Buy
52,902
+27,780
+111% +$699K 0.1% 371
2022
Q1 		$647K Buy
+25,122
New +$667K 0.04% 715
2018
Q4 		– Sell
-13,130
Closed -$377K – 422
2018
Q3 		$377K Hold
13,130
– – 0.08% 279
2018
Q2 		$358K Buy
+13,130
New +$350K 0.07% 267

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Algert Global's TVTX Position: Q2 2026 in Review

Algert Global reduced its Travere Therapeutics (TVTX) stake by 6% in Q2 2026, selling an estimated $467K and leaving 166,372 shares worth $9.45M. The position accounts for 0.11% of the portfolio, ranked #286.

Algert Global first reported a position in TVTX in Q2 2018 and has held it in 16 quarters since. 319 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Algert Global held 166,372 shares of Travere Therapeutics worth $9.45M as of Q2 2026.
  • Algert Global sold 10,536 Travere Therapeutics shares in Q2 2026, an estimated $467K.
  • Travere Therapeutics made up 0.11% of Algert Global's portfolio in Q2 2026, its #286 holding.
  • Algert Global first reported a position in Travere Therapeutics in Q2 2018 and has held it in 16 quarters since.
  • 319 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.